Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant POF for Locally Advanced Gastric Cancer
NCT04149015Phase 2Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Nov 2019
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, oxaliplatin, fluorouracil in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injectionoxaliplatinfluorouracil
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT04149015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149015.